Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.
OBJECTIVE: Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in...
Κύριοι συγγραφείς: | Miskowiak, K, Vinberg, M, Harmer, C, Ehrenreich, H, Kessing, L |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2012
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
ERYTHROPOIETIN - A CANDIDATE TREATMENT FOR MOOD SYMPTOMS AND COGNITIVE DYSFUNCTION IN DEPRESSION
ανά: Miskowiak, K, κ.ά.
Έκδοση: (2011) -
Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.
ανά: Miskowiak, K, κ.ά.
Έκδοση: (2016) -
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
ανά: Miskowiak, K, κ.ά.
Έκδοση: (2010) -
Neural correlates of improved executive function following erythropoietin treatment in mood disorders
ανά: Miskowiak, K, κ.ά.
Έκδοση: (2016) -
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
ανά: Paulson Olaf B, κ.ά.
Έκδοση: (2010-10-01)